18.05.2018 • NewsElaine BurridgeEurochem

EuroChem Exits Ukraine Fertilizer Market

EuroChem Exits Ukraine Fertilizer Market (c) EuroChem
EuroChem Exits Ukraine Fertilizer Market (c) EuroChem

Declining business conditions in Ukraine have prompted Swiss fertilizer group EuroChem to sell its subsidiary there, after more than 15 years of operations.

EuroChem said the country’s recent actions to restrict foreign supplies of fertilizer and expectations of a further deterioration of the business climate were behind its decision. The company added that it had invested considerable resources in the country to meet growing demand from more than 1,000 customers, ranging from major agricultural wholesalers to retailers and private farms.

An undisclosed company connected to the subsidiary’s former management has bought the business. Financial terms were not revealed.

EuroChem said it intends to continue consulting with the Ukrainian authorities on future opportunities through its European operations, while focusing on other growth markets.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.